Basophil CD203c Levels Are Increased at Baseline and Can Be Used to Monitor Omalizumab Treatment in Subjects with Nut Allergy

Publisher： Karger

E-ISSN： 1423-0097|154|4|318-327

ISSN： 1018-2438

Source： International Archives of Allergy and Immunology, Vol.154, Iss.4, 2010-10, pp. : 318-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Basophil-Specific Ectoenzyme E-NPP3 (CD203c) as a Marker for Cell Activation and Allergy Diagnosis

By  

International Archives of Allergy and Immunology, Vol. 133, Iss. 4, 2004-04 ,pp. : 317-329

Karger

Access to resources Recommend Favorite

Omalizumab in the treatment of allergy and asthma

By Lanier Bob   Carr Warner  

Therapy, Vol. 1, Iss. 1, 2004-09 ,pp. : 25-30

Future Medicine

Access to resources Recommend Favorite

Allergen-Induced Basophil CD203c Expression as a Biomarker for Rush Immunotherapy in Patients with Japanese Cedar Pollinosis

By  

International Archives of Allergy and Immunology, Vol. 146, Iss. 1, 2008-05 ,pp. : 47-53

Karger

Access to resources Recommend Favorite

Basophil Activation Marker CD203c Is Useful in the Diagnosis of Hen’s Egg and Cow’s Milk Allergies in Children

By  

International Archives of Allergy and Immunology, Vol. 152, Iss. 1, 2010-06 ,pp. : 54-61

Karger

Access to resources Recommend Favorite

Individual Hymenoptera Venom Compounds Induce Upregulation of the Basophil Activation Marker Ectonucleotide Pyrophosphatase/Phosphodiesterase 3 (CD203c) in Sensitized Patients

By  

International Archives of Allergy and Immunology, Vol. 129, Iss. 2, 2002-10 ,pp. : 160-168

Karger

Access to resources Recommend Favorite